It is how it is !!! 💪😎💚🍻 #CIS2022 #CommunityIndieShowcase2022 #GoldenAgeOfGaming

Today we proudly presented in #CIS2022 the results of CoviDCELL in immunocompetent young adults comparing Astra/Astra or Astra/Pfizer Covid vaccines as a straightforward method to be used in large populations @ClinImmSoc #somosHUC @SanidadGobCan

In phase 3 placebo controlled RCT for treatment of #APDS —leniolisib decreased lymphadenopathy, increased % naive B cells, decreased % transitional B cells, and decreased spleen size. Future is bright for personalized medicine #CIS2022

Presidential award. Everybody loves Kate. #CIS2022

El reto de los laboratorios asistenciales: traducir la enorme cantidad de datos de la secuenciación masiva a la clínica #CIS2022

Disease manifestations of x linked CGD “carriers”…everything we learned in med school about x linked carriers is wrong. They can manifest disease due to non-random lyonization #CIS2022

Molecular explanation to “common” infections with severe presentations is one of the coolest things in clinical immunology. DECTIN-1, PLGC2, DUOX1, DUOXA1 explain >50% of severe disseminated cocci/valley fever #CIS2022

Seroconversion rate after two doses #COVID19 vaccine in patients with CVID, however not always neutralizing. Low IgA and switched mem B cells predicts lack of conversion. Data supports 3 dose primary series in these patients #CIS2022

Ludwig Boltzmann Institute’s Daniel Mayr describes a new IEI: IKZF2, #CIS2022

I love my chaotic lab #CIS2022

⁦@louisemalle1⁩ describes her work with ⁦@BogunovicLab⁩ at #CIS2022 on immune tolerance in #DownSyndrome

Desde Parque Central Zona Franca agradecemos el reconocimiento WHY CARTAGENA, otorgado bajo el marco del evento Cartagena&Bolívar Investment Summit 2022, por generar impacto positivo en materia de desarrollo económico y social en el territorio. #InvestmentSummit2022 #CIS2022

Today’s the day! Don’t forget to tune in to the #insecm #CIS2022 summit! See you there 👋

Cost of genetic testing is now comparable to many “common” labs, yet insurance companies continue to deny coverage and call it “experimental” despite it being standard care #CIS2022

As a young Immunologist, it’s incredible to me that WES and panel testing has only been used clinically for IEI over the past 10 years. I take it for granted that I have this test easily available in my diagnosis arsenal. Texas Children’s Dr. Ivan Chinn #CIS2022

First conference travel in 2+ years! I cannot wait to see colleagues and discuss #immunogenomics at #CIS2022. @ClinImmSoc

As a member of ⁦@ClinImmSoc⁩ Early Career Immunologist Committee, I was honored to co-moderate the #CIS2022 Rose/Faley Lectureship given to Duke’s Dr. Michael Hershfield for his incredible work the past 5 decades on purine metabolism.

First in human Treg replacement trial open…converting CD4 cells into Treg with gene therapy. Blows my mind what will be available clinically in next 5, 10, 15 years #CIS2022 #IPEX #GeneTherapy

Primary immunodeficiencies (PI) such as APDS can be elusive. They can present with many varied signs & symptoms, making them difficult to diagnose. If you’re at #CIS2022, visit booth 103 to learn more about APDS.